When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DEST - Destiny Pharma looking to move on to phase III with XF-73 nasal gel
Destination Maternity Corporation
(NewsDirect)
Destiny Pharma PLC (AIM:DEST, OTC:DTTYF)chief executive Neil Clark speaks to Thomas Warner from Proactiveafter publishing research about the company's new nasal gel,called XF-73, in the US journal 'Infection Control & HospitalEpidemiology'.
Clark explains more about the benefits of thegel and how it works, and confirms that the plan is to find a partnerto help fund a phase III study.